These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23269394)

  • 1. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice.
    Assini JM; Mulvihill EE; Sutherland BG; Telford DE; Sawyez CG; Felder SL; Chhoker S; Edwards JY; Gros R; Huff MW
    J Lipid Res; 2013 Mar; 54(3):711-724. PubMed ID: 23269394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
    Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr
    Burke AC; Sutherland BG; Telford DE; Morrow MR; Sawyez CG; Edwards JY; Huff MW
    Atherosclerosis; 2019 Jul; 286():60-70. PubMed ID: 31102954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
    Mulvihill EE; Allister EM; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Markle JM; Hegele RA; Huff MW
    Diabetes; 2009 Oct; 58(10):2198-210. PubMed ID: 19592617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese
    Burke AC; Sutherland BG; Telford DE; Morrow MR; Sawyez CG; Edwards JY; Drangova M; Huff MW
    J Lipid Res; 2018 Sep; 59(9):1714-1728. PubMed ID: 30008441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial Effects of Moderate Hepatic Activin A Expression on Metabolic Pathways, Inflammation, and Atherosclerosis.
    Liu H; Hallauer Hastings M; Kitchen R; Xiao C; Baldovino Guerra JR; Kuznetsov A; Rosenzweig A
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):330-349. PubMed ID: 36453275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-induced hepatic inflammation does not underlie the predisposition to insulin resistance in dyslipidemic female LDL receptor knockout mice.
    Gruben N; Funke A; Kloosterhuis NJ; Schreurs M; Sheedfar F; Havinga R; Houten SM; Shiri-Sverdlov R; van de Sluis B; Kuivenhoven JA; Koonen DP; Hofker MH
    J Diabetes Res; 2015; 2015():956854. PubMed ID: 25815343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity.
    Bojic LA; Telford DE; Fullerton MD; Ford RJ; Sutherland BG; Edwards JY; Sawyez CG; Gros R; Kemp BE; Steinberg GR; Huff MW
    J Lipid Res; 2014 Jul; 55(7):1254-66. PubMed ID: 24864274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr
    Burke AC; Telford DE; Edwards JY; Sutherland BG; Sawyez CG; Huff MW
    Mol Nutr Food Res; 2019 Mar; 63(6):e1800833. PubMed ID: 30578663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice.
    Subramanian S; Han CY; Chiba T; McMillen TS; Wang SA; Haw A; Kirk EA; O'Brien KD; Chait A
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):685-91. PubMed ID: 18239153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of intestinal cholesterol absorption decreases atherosclerosis but not adipose tissue inflammation.
    Umemoto T; Subramanian S; Ding Y; Goodspeed L; Wang S; Han CY; Teresa AS; Kim J; O'Brien KD; Chait A
    J Lipid Res; 2012 Nov; 53(11):2380-9. PubMed ID: 22956784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.
    Tu P; Bhasin S; Hruz PW; Herbst KL; Castellani LW; Hua N; Hamilton JA; Guo W
    Diabetes; 2009 Aug; 58(8):1739-48. PubMed ID: 19509018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice.
    Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice.
    Ke JY; Banh T; Hsiao YH; Cole RM; Straka SR; Yee LD; Belury MA
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28370954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue.
    Bie J; Zhao B; Song J; Ghosh S
    J Biol Chem; 2010 Apr; 285(18):13630-7. PubMed ID: 20189995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.